Biotech Opportunities And Risks In Q2 – And Beyond
After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 –…
After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 –…
Looking for “exciting biotech plays that won’t break the bank”? Today’s article highlights three such plays, all of which are trading under $3 per share,…